Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  UNITEDHEALTH GROUP INC
 2. Date of Event Requiring Statement (Month/Day/Year)
11/17/2017		 3. Issuer Name and Ticker or Trading Symbol
Evolent Health, Inc. [EVH]
(Last)
(First)
(Middle)
UNITEDHEALTH GROUP INCORPORATED, 9900 BREN ROAD EAST		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
_____ Officer (give title below) __X__ Other (specify below)
Director by Deputization
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

MINNETONKA, MN 55343		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Class A Common Stock, par value $0.01 per share 4,128,167
I (1) (2)
See footnote (1) (2)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Class B Units and Class B Common Stock   (3)(4)   (3)(4) Class A Common Stock, par value $0.01 per share 1,772,898 $ (3) I (1) (2) See footnote (1) (2)

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
UNITEDHEALTH GROUP INC
UNITEDHEALTH GROUP INCORPORATED
9900 BREN ROAD EAST
MINNETONKA, MN 55343		   X     Director by Deputization

Signatures

UnitedHealth Group Incorporated By: /s/ Dannette L. Smith, Name: Dannette L. Smith, Title: Secretary to the Board of Directors 11/27/2017
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The Advisory Board Company, a Delaware corporation ("ABCO"), is the record and direct beneficial owner of the Class A Common Stock (including the Class A Common Stock issuable upon the exchange of the Class B Units owned directly by ABCO). ABCO is a direct, wholly owned subsidiary of OptumInsight, Inc., a Delaware corporation ("OptumInsight"), and OptumInsight may be deemed to beneficially own securities directly owned by ABCO. OptumInsight is a direct, wholly owned subsidiary of OptumInsight Holdings, LLC, a Delaware limited liability company ("Holdings"), and Holdings may be deemed to beneficially own securities beneficially owned by OptumInsight. Holdings is a direct, wholly owned subsidiary of Optum, Inc., a Delaware corporation ("Optum"), and Optum may be deemed to beneficially own securities beneficially owned by Holdings.
(2) (cont. from footnote 1) Optum is a direct, wholly owned subsidiary of United HealthCare Services, Inc., a Minnesota corporation ("UHS"), and UHS may be deemed to beneficially own securities beneficially owned by Optum. UHS is a direct, wholly owned subsidiary of UnitedHealth Group Incorporated, a Delaware corporation ("UNH"), and UNH may be deemed to beneficially own securities beneficially owned by UHS.
(3) Pursuant to the terms of the Exchange Agreement dated as of June 4, 2015, by and among Evolent Health, Inc. (the "Issuer"), Evolent Health, LLC and the holders from time to time of Class B Common Units (the "Class B Units") of Evolent Health, LLC listed in Exhibit A thereto (the "Exchange Agreement"), ABCO may exchange its Class B Units (along with a corresponding number of its Class B Common Stock) for Class A Common Stock of the Issuer on a one-for-one basis, subject to adjustment pursuant to the terms of the Exchange Agreement and the Third Amended and Restated Operating Agreement entered into on June 4, 2015 among the Issuer, ABCO and the other members party thereto.
(4) ABCO holds an aggregate of 1,772,898 Class B Units of Evolent Health, LLC and 1,772,898 Class B Shares of the Issuer.
 
Remarks:
Solely for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the Reporting Person may be deemed to be a "director by deputization" by virtue of certain rights of ABCO, an indirect wholly owned subsidiary of the Reporting Person, to appoint up to two representatives to the board of directors of the Issuer pursuant to that certain Stockholders Agreement by and among the Issuer, ABCO and certain other parties thereto, dated as of June 4, 2015.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.